There was a significant association for CD38+ CLL B-cells to have higher apoptosis induction levels when exposed to TP-0903 (p=0.02) [Supplementary Figure 4A] in patients exposed to ibrutinib. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.